An Observational Study of Smoflipid vs Intralipid on the Evolution of Intestinal Failure-Associated Liver Disease in Infants With Intestinal Failure.
Christina BelzaJohn C WalesGlenda Courtney-MartinNicole de SilvaYaron AvitzurPaul W WalesPublished in: JPEN. Journal of parenteral and enteral nutrition (2019)
Use of SMOFlipid resulted in decreased development of IF-associated liver disease in patients with IF when assessed using biochemical tests.
Keyphrases